Peer-influenced content. Sources you trust. No registration required. This is HCN.
MDLinx
Defamation lawsuits were brought into the limelight with the Johnny Depp vs. Amber Heard lawsuit, and physicians can learn a lot from the questions brought into the case, and most importantly, that even if you win the courtroom case, as Depp did, it can represent a loss in your real life.
All Specialties June 29th 2022
JAMA Network
The story of David Ho, MD, who contracted the COVID-19 virus after attending a conference on the virus(!), but who lived COVID-free for two years beforehand. The Paxlovid he took eliminated the symptoms and he was free from the virus after testing. However, a few days later, he felt sick again and tested himself. Lo and behold, COVID returned. Is it the drug or is it the virus causing this phenomenon?
People who are fully vaccinated against COVID-19 have a shorter duration of viable viral shedding and a lower secondary attack rate than partially vaccinated or unvaccinated people. Data from this study provides important evidence that despite the possibility of breakthrough infections, COVID-19 vaccinations remain critically useful for controlling the spread of SARS-CoV-2.
All Specialties June 7th 2022
Monkeypox has never before appeared more or less simultaneously across different countries and now continents. So this current outbreak is both puzzling and concerning public health workers. Unlike the previous cases discovered outside Africa, the current outbreaks have occurred in people with no travel history, suggesting that human-to-human transmission is driving the spread. And in the current outbreak, the illness appears to be presenting atypically, without its normal prodrome. Read more about the hypothesized connection with smallpox eradication, available vaccinations, and public health response from the outbreak.
Medical Professionals Reference (MPR)
The CDC continue to recommend Paxlovid for early-stage treatment of mild-to-moderate COVID-19 among individuals at high risk of progression to severe disease. Recent case reports suggest that some patients treated with Paxlovid may have a recurrence of COVID-19 symptoms two to eight days after completing the five-day course of treatment. Both the illness and the positive test results resolved, on average, three days later without the need for additional treatment.
All Specialties May 31st 2022
MashupMD
The US is in the midst of another surge in COVID-19 infections heading into the summer. A GWU physician feels CDC are misserving the country by downplaying the surge and hiding the real data behind an “all green” map.